• Darling Ingredients’ Health Brand, Rousselot, the global leader in collagen-based solutions, and Gelomics, the world-leading provider of fully integrated 3D cell, organoid and tissue culture technologies, have entered into a co-branding partnership. Rousselot Biomedical will supply Gelomics with its X-Pure GelMA (gelatin methacryloyl), a photo cross-linkable extracellular matrix, for use…

    Read More
  • New wearable biomaterial inks, that mimic native characteristics of highly conductive human tissue, were developed by Texas A&M researchers.

    A team of researchers at Texas A&M University has developed a new class of biomaterial inks that mimic native characteristics of highly conductive human tissue, much like skin, which are essential for the ink to be used in 3D printing. This biomaterial ink leverages a new class of 2D nanomaterials…

    Read More
  • GrowInk UPM

    Just like in any segment of additive manufacturing (polymers, metals, ceramics, composites), the market for bioprinting inks—or bioinks—is the key element to understanding, determining and assessing the evolution of the entire segment. Bioprinting hardware technologies are now more established and the development of viable bioprinting applications is now dependent on…

    Read More
  • The risk has never been higher than in recent times as brave and passionate entrepreneurs attempt to pave the way for this new world of three-dimensional (3D) lab-grown cell cultivated, plant-based & hybrid meat, fish, and other food alternatives. The demand for alternative meat and the removal of animals from…

    Read More
  • North Carolina-based biotech startup Jellatech reached a major milestone with the production of cell-based collagen. Only 2 years since it was founded, Jellatech successfully developed of a full-length, triple helical and functional collagen made from their own proprietary cell lines. ​ “This is a major milestone for us and I…

    Read More
  • Humabiologics and REGEMAT 3D to provide human-derived biomaterials. Giving access to the European bioprinting and drug testing market.

    Humabiologics, an industry leader in providing human-derived biomaterials for regenerative medicine, and REGEMAT 3D, a company at the forefront of personalized biofabrication solutions, have entered into a non-exclusive distribution agreement, in a response to the growing demand, and to serve a broader life sciences customer base of industry partners and…

    Read More
  • Vivid color 3D printing ink developed by Chinese scientists. According to South China Morning Post, the biocompatible ink

    According to a report by South China Morning Post, Chinese scientists have developed a vivid 3D printing ink, that does not contain colorants, and is safe to use in toys that change color in relation to body temperature, and food decorations. Although, it is safe to assume that there are…

    Read More
  • Humabiologics partners with Fisher Scientific. To distribute human biomaterials for regenerative medicine research.

    Humabiologics, an industry leader in providing human-derived biomaterials for regenerative medicine, founded by scientists and tissue industry experts to address the gap between the gift of donated human tissues and researchers, and Fisher Scientific, a global leader in life sciences, are partnering to serve researchers in academia and industry who…

    Read More
  • Rousselot, Darling Ingredients’ health brand, and the global leader in collagen-based solutions launched its GMP grade GelMA bioink. According to the company, X-Pure GelMA is the first gelatin methacryloyl, or GelMA, on the market to be produced under GMP conditions. Good manufacturing practice (GMP) describes the minimum standard that a medicines…

    Read More
  • Rousselot, Darling Ingredients’ health brand and the world’s leader of collagen-based solutions, has partnered with the Terasaki Institute for Biomedical Innovation (TIBI), a California-based research institute focused on regenerative medicine. Through this strategic partnership, Rousselot and TIBI will collaborate on the development of gelatin-based therapies and their translation to the…

    Read More
Back to top button

We use cookies to give you the best online experience and for ads personalisation. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services



Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*